Blog

CKBR-12 An Ibogaine Derivative Medicine For Parkinson’s

CKBR-12 Parkinson Treatment – A Novel Ibogaine Derivative Medicine CKBR-12 Parkinson Treatment is an emerging ibogaine derivative medicine currently being evaluated for its effectiveness in reducing both motor and[…]

Ibogaine Treatment for Parkinson’s Disease

Ibogaine treatment for Parkinson’s disease is an emerging approach being studied for its potential effects on motor and non-motor symptoms of PD. More than 55 million people globally suffer[…]

The Long, Strange Trip of Rick PerryThe former Texas governor and Trump energy secretary has now dedicated his life to promoting the powerful psychedelic ibogaine.

The Long, Strange Trip of Rick PerryThe former Texas governor and Trump energy secretary has now dedicated his life to promoting the powerful psychedelic ibogaine.Robert DraperBy Robert DraperReporting from[…]

senate budget fund

Senate budget would fund first-in-the-nation study of Ibogaine treatment for opioid use disorder

Home / News Release / Senate budget would fund first-in-the-nation study of ibogaine treatment for opioid use disorder A proviso in the Washington Legislature’s supplemental operating budget would direct[…]

Understanding Ibogaine Treatment for Various Addictions

Ibogaine Treatment For Various Addictions is an emerging therapeutic approach being explored for its role in addiction recovery and withdrawal management. In today’s post, we will take an in-depth[…]

How Ibogaine Rewires the Brain

The Day I Was Lobotomised by a Plant 15 minute read Much has been written in recent times about the benefits of psychedelic/oneiro genic plant medicines in treating addiction[…]

Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction

Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction

New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains illegal in the U.S.[…]